In patients with NAFLD, adiponectin’s circulating levels are found to be decreased, and some of its polymorphisms, such as rs266729 has been correlated with NAFLD, its severity, even with the grade of inflammation and necrosis [103]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.